Hatem A Abdel-Aziz Selected Research

Hatem A Abdel-Aziz Research Topics

Disease

37	Neoplasms (Cancer) 12/2022 - 02/2010
8	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2016
5	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 10/2017
3	Colonic Neoplasms (Colon Cancer) 12/2021 - 12/2018
3	Triple Negative Breast Neoplasms 12/2018 - 07/2016
2	Edema (Dropsy) 01/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 06/2016 - 08/2014
1	Leukemia 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Pneumonia (Pneumonitis) 12/2021
1	Bronchitis 12/2021
1	Tuberculosis (Tuberculoses) 12/2021
1	Glaucoma 01/2020
1	Necrosis 10/2019
1	Kidney Neoplasms (Kidney Cancer) 01/2019
1	Retinoblastoma (Glioblastoma, Retinal) 12/2018
1	Asthma (Bronchial Asthma) 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Carcinogenesis 02/2016
1	Hepatocellular Carcinoma (Hepatoma) 07/2015
1	Colitis 04/2015
1	Lung Neoplasms (Lung Cancer) 08/2014
1	Ulcer 06/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2012

Drug/Important Bio-Agent (IBA)

17	Protein Isoforms (Isoforms)IBA 01/2022 - 03/2013
12	Carbonic Anhydrases (Carbonic Anhydrase)IBA 04/2021 - 03/2013
9	IsatinIBA 12/2021 - 05/2012
8	BenzenesulfonamidesIBA 01/2020 - 03/2013
7	SulfonamidesIBA 01/2022 - 01/2017
5	Antineoplastic Agents (Antineoplastics)IBA 12/2021 - 07/2016
4	Biological ProductsIBA 01/2019 - 07/2015
4	EnzymesIBA 01/2019 - 02/2010
3	Carboxylic AcidsIBA 01/2022 - 05/2020
3	Celecoxib (Celebrex)FDA Link 01/2022 - 06/2014
3	benzofuranIBA 12/2021 - 05/2020
3	Carbonic Anhydrase InhibitorsIBA 05/2020 - 03/2013
3	PyrimidinesIBA 01/2019 - 08/2014
2	Benzofurans (Coumarones)IBA 12/2022 - 12/2020
2	CoumarinsIBA 12/2022 - 01/2022
2	CarrageenanIBA 01/2022 - 01/2019
2	SulfonesIBA 06/2021 - 02/2015
2	SLC-0111IBA 04/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 04/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2018
2	Sunitinib (Sutent)FDA Link 12/2018 - 01/2017
2	QuinazolinesIBA 01/2018 - 12/2017
2	HydrazinesIBA 12/2017 - 01/2016
2	Caspase 3 (Caspase-3)IBA 01/2017 - 08/2014
1	PyridinesIBA 01/2022
1	coumarinIBA 01/2022
1	piperineIBA 12/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Fluorouracil (Carac)FDA LinkGeneric 12/2021
1	Streptomycin (Streptomycin Sulfate)FDA Link 12/2021
1	AcidsIBA 05/2020
1	indoleIBA 04/2020
1	tetralinIBA 04/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2020
1	2-oxindole (oxindole)IBA 04/2020
1	SaccharinIBA 01/2020
1	Sweetening Agents (Sweeteners)IBA 01/2020
1	acetosulfame (acesulfame K)IBA 01/2020
1	pyridineIBA 12/2019
1	Cysteine (L-Cysteine)FDA Link 10/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019
1	quinolineIBA 01/2019
1	ThiazolesIBA 01/2019
1	SpirooxindolesIBA 12/2018
1	benzimidazoloneIBA 12/2018
1	OxindolesIBA 12/2018
1	Hydro-Lyases (Dehydratases)IBA 12/2018
1	Retinoblastoma ProteinIBA 12/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	phthalazineIBA 12/2017
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2017
1	lissamine rhodamine B (sulforhodamine B)IBA 06/2016
1	chetominIBA 02/2016
1	pyrazoleIBA 10/2015
1	indolineIBA 07/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2015
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2015
1	Schiff Bases (Schiff Base)IBA 05/2012
1	TransferasesIBA 02/2010
1	CarcinogensIBA 02/2010
1	Epoxide HydrolasesIBA 02/2010
1	Glutathione (Reduced Glutathione)IBA 02/2010
1	hydroxide ionIBA 02/2010
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 02/2010

Therapy/Procedure

1	Microspheres (Microsphere) 01/2017
1	Therapeutics 01/2017